Interactions between conventional psychiatric treatments like SSRIs and psychedelic drugs can occur at multiple levels, including peripheral pharmacokinetic interactions, central pharmacokinetic interactions (such as competition at the 5-HT2AR), or pharmacodynamic interactions affecting second messenger systems or neuroplasticity.

Authors

• Person: Not available Organization: Nature
  Neuroimaging in psychedelic drug development: past, present, and ...

Sources

• Neuroimaging in psychedelic drug development: past, present, and ... www.nature.com Nature via serper

Referenced by nodes (2)

• psychedelic drugs concept
• 5-HT2AR concept